Australia: Pfizer Australia plans to take ResApp Health private

Pfizer Australia Holdings, a wholly-owned subsidiary of global biopharmaceutical company Pfizer, is intending to acquire 100% of the shares in ASX listed ResApp Health, a Brisbane-based digital health company developing smartphone applications for the diagnosis and management of respiratory disease. Under the Scheme of Arrangement, Pfizer Australia will acquire the shares for A$0.115 per share…

You must be a HMI Subscriber to view this content.

Subscribe Now »